Pre-Exposure Prophylaxis (PrEP) Trials Working Group
SEP-07-08 The Pre-Exposure Prophylaxis (PrEP) Trials Working Group was established in September 2008 with funding from the Bill and Melinda Gates Foundation under the aegis of the Forum for Collaborative HIV research. Its establishment followed discussions held by various PrEP trial investigators concerning the need and desire for a neutral forum in which PrEP trial investigators and sponsors could convene for the purpose of sharing information, coordinating current and future research activities, plan for dissemination of trial results, and collaboratively discussing implications of trial results for future HIV prevention research and programmatic activities.
Read more »
Consultation on the Inclusion of Adolescents in HIV Biomedical Prevention Clinical Trials
JUN-17-09 In collaboration with Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute of Mental Health, National Institute on Drug Abuse, National Institute of Allergy and Infectious Diseases, and the Office of AIDS Research. This consultation will focus on examining and discussing the desirability and timing of as well as barriers to enrollment of adolescents in these trials. Participants will include representatives from academia, industry, HIV-affected communities, and various branches of the United States government. These participants will offer an expanse of expertise covering the medical, behavioral, ethical, legal and regulatory ramifications of including or not including adolescents in biomedical prevention trials.
Read more »